References: 

References
1. Anderson JC, Williams S, McGee R, Silva PA (1987), DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry 44(1):69-76.
2. Biederman J, Monuteaux M, Mick E et al. (in press-a), Young adult outcome of attention deficit hyperactivity disorder: a controlled 10 year prospective follow-up study. Psychol Med.
3. Biederman J, Monuteaux M, Mick E et al. (in press-b), Is cigarette smoking a gateway drug to subsequent alcohol and illicit drug use disorders? A controlled study of youths with and without ADHD. Biol Psychiatry.
4. Biederman J, Wilens T, Mick E et al. (1997), Is ADHD a risk for psychoactive substance use disorder? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 36(1):21-29.
5. Carroll KM, Rounsaville BJ (1993), History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 34(2):75-82.
6. DeMilio L (1989), Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry 146(9):1212-1214.
7. Drug Enforcement Administration (1995), Methylphenidate Review Document. Washington, D.C.: Office of Diversion Control, Drug and Chemical Evaluation Section.
8. Faraone SV, Wilens T (2003), Does stimulant treatment lead to substance use disorders? J Clin Psychiatry 64(suppl 11):9-13.
.9 Gignac M, Wilens TE, Biederman J et al. (2005), Assessing cannabis use in adolescents and young adults: what do urine screen and parental report tell you? J Child Adolesc Psychopharmacol 15(5):742-750.
10. Grabowski J, Shearer J, Merrill J, Negus SS (2004), Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29(7):1439-1464.
11. Heil SH, Holmes HW, Bickel WK et al. (2002), Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 67(2):149-156.
12. Katusic SK, Barbaresi WJ, Colligan RC et al. (2005), Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population based, birth cohort study. J Child Adolesc Psychopharmacol 15(5):764-776.
13. Kessler R (in press), A recent replication of the National Comorbidity Study estimating the prevalence of adult ADHD among persons 18-44 in the US. Psychol Med.
14. Kessler RC (2004), The epidemiology of dual diagnosis. Biol Psychiatry 56(10):730-737.
15. Levin FR, Evans SM (2001), Diagnostic and treatment issues in comorbid substance abuse and adult attention-deficit hyperactivity disorder. Psychiatric Annals 31(5):303-312.
16. Mannuzza S, Klein RG, Bessler A et al. (1993), Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50(7):565-576.
17. Marsh LD, Kay JD, Payne TP (2000), Methylphenidate misuse in substance abusing adolescents. Journal of Child and Adolescent Substance Abuse 9(3):1-14.
18. Milberger S, Biederman J, Faraone SV et al. (1997a), ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 36(1):37-44.
19. Milberger S, Biederman J, Faraone SV et al. (1997b), Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict 6(4):318-329.
20. Milin R, Halikas JA, Meller JE, Morse C (1991), Psychopathology among substance abusing juvenile offenders. J Am Acad Child Adolesc Psychiatry 30(4):569-574.
21. Molina BS, Pelham WE (2003), Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 112(3):497-507.
22. Monuteaux MC (2004), A randomized, double-blind, placebo-controlled clinical trial of bupropion for the prevention of smoking in youth with attention-deficit/hyperactivity disorder. Presented at the National Cancer Institute's Tobacco Investigators' Meeting: Synthesizing Research for the Public's Health. San Diego; June 2-4.
23. Musser CJ, Ahmann PA, Theye FW et al. (1998), Stimulant use and potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. J Dev Behav Pediatr 19(3):187-192.
24. Poulin C (2001), Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CMAJ 165(8):1039-1044 [see comment].
25. Riggs PD (1998), Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 37(3):331-332.
26. Riggs PD, Hall SK, Mikulich-Gilbertson SK et al. (2004), A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 43(4):420-429.
27. Schubiner H, Saules KK, Arfken CL et al. (2002), Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10(3):286-294.
28. Trauth JA, Seidler FJ, Slotkin TA (2000), Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res 880(1-2):167-172.
29. Vitiello B (2001), Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 11(1):25-34.
30. Volkow ND, Wang GJ, Fowler JS et al. (1998), Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155(10):1325-1331.
31. Weiss G (1992), Child and Adolescent Psychiatric Clinics of North America: Attention-Deficit/Hyperactivity Disorder. Philadelphia: W.B. Saunders Company.
32. Wilens TE, Biederman J, Spencer TJ (2002), Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 53:113-131.
33. Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003), Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111(1):179-185.
34. Wilens TE, Gignac M, Swezey A et al. (in press-a), Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry.
35. Wilens TE, Monuteaux MC, Snyder LE, Moore H (2005), The clinical dilemma of using medications in substance abusing adolescents and adults with ADHD: what does the literature tell us? J Child Adolesc Psychopharmacol 15(5):787-798.
36. Wilens TE, Verlinden MH, Adler LA et al. (in press-b), ABT-089, a neuronal nicotinic receptor modulator, for the treatment of ADHD in adults: results of a pilot study. Biol Psychiatry.